Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2889PDF: 1114HTML: 126 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1437PDF: 838HTML: 3125 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3287PDF: 1040HTML: 2134 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1079PDF: 973Suppl. Files: 469HTML: 308 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2750PDF: 1028HTML: 2377 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1650PDF: 904HTML: 3161Figure 5: 160Figure 4: 162Figure 3: 197Figure 1: 177Figure 2: 173 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4257PDF: 1504HTML: 8524 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1635PDF: 818HTML: 1242Figure 1: 183Figure 2: 196Figure 3: 194 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1023PDF: 478HTML: 131 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1891PDF: 861HTML: 1597 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3366PDF: 593HTML: 676 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1460PDF: 1344HTML: 110 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1607PDF: 863HTML: 1042Picture 1: 179 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1621PDF: 1001HTML: 208 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1917PDF: 810HTML: 3613 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
748PDF: 474HTML: 6274 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4373PDF: 1222HTML: 2328Figure 1: 176 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1554PDF: 1255HTML: 517 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4600PDF: 1956HTML: 17861 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8136PDF: 4316HTML: 7519 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1645PDF: 1316HTML: 152 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1212PDF: 847HTML: 2190Figue 1: 182







